A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the α-fetoprotein promoter

British Journal of Cancer

Volumn 89, Issue 6, 2003, Pages 1086-1090

  Tomizawa, M ^a,b   Yu, L ^a   Wada, A ^a,b   Tamaoki, T ^c   Kadomatsu, K ^d   Muramatsu, T ^d   Matsubara, S ^e   Watanabe, K ^a   Ebara, M ^b   Saisho, H ^b   Sakiyama, S ^a   Tagawa, M ^a  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF CALGARY   (Canada)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

fetoprotein; Hepatocellular carcinoma; HSV TK; Midkine; Promoter

Indexed keywords

ALPHA FETOPROTEIN; GANCICLOVIR; MESSENGER RNA; MIDKINE; PRODRUG; THYMIDINE KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENHANCER REGION; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUSION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOMIC FRAGMENT; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SUICIDE GENE;

AGED; ALPHA-FETOPROTEINS; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; LUCIFERASES; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; SIMPLEXVIRUS; THYMIDINE KINASE; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0141921840     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601246     Document Type: Article

References (25)

1. Adachi Y, Reynolds PN, Yamamoto M, Grizzle WE, Overturf K, Matsubara S, Muramatsu T, Curiel DT (2000) Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors. Cancer Res 60: 4305-4310
2. Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T, Muramatsu T (1995) Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 86: 655-661
3. Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R (1997) An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57: 1814-1819
4. Di Bisceglie AM, Dusheiko GM, Paterson AC, Alexander J, Shouval D, Lee CS, Beasley RP, Kew MC (1986) Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue. Br J Cancer 54: 779-785
5. Hallenbeck PL, Chang YN, Hay C, Golightly D, Stewart D, Lin J, Phipps S, Chiang YL (1999) A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma. Hum Gene Ther 10: 1721-1733
6. Heise C, Kirn DH (2000) Replication-selective adenoviruses as oncolytic agents. J Clin Invest 105: 847-851
7. Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H (2001) Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human α-fetoprotein promoter. Cancer Res 61: 3016-3021
8. Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K (1999) Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma. Gene Ther 6: 465-470
9. Kadomatsu K, Tomomura M, Muramatsu T (1988) cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 1312-1318
10. Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H, Muramatsu T (1997) Midkine induces the transformation of NIH3T3 cells. Br J Cancer 75: 354-359
11. Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M (1996) Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology 23: 1359-1368
12. Koide N, Hada H, Shinji T, Ujike K, Hirasaki S, Yumoto Y, Hanafusa T, Kadomatsu K, Muramatsu H, Muramatsu T, Tsuji T (1999) Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology 46: 3189-3196
13. Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K (1998) Retrovirus-mediated gene therapy for hepatocellular carcinoma: Selective and enhanced suicide gene expression regulated by human α-fetoprotein enhancer directly linked to its promoter. Cancer Gene Ther 5: 301-306
14. Miller N, Whelan J (1997) Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 8: 803-815
15. Miyauchi M, Yoshida Y, Tada Y, Narita M, Maeda T, Bahar R, Kadomatsu K, Muramatsu T, Matsubara S, Nakagawara A, Sakiyama S, Tagawa M (2001) Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer 91: 723-727
16. Morinaga T, Sakai M, Wegmann TG, Tamaoki T (1983) Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci USA 80: 4604-4608
17. Nakabayashi H, Hashimoto T, Miyao Y, Tjong KK, Chan J, Tamaoki T (1991) A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma. Mol Cell Biol 11: 5885-5893
18. Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shiina S, Okudaira T, Ikeda Y, Inoue T, Omata M (1996) Quantitation of alpha-fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma. Hepatology 23: 1384-1392
19. Otsuru A, Nagataki S, Koji T, Tamaoki T (1988) Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization. Cancer 62: 1105-1112
20. Takei Y, Kadomatsu K, Matsuo S, Itoh H, Nakazawa K, Kubota S, Muramatsu T (2001) Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells. Cancer Res 61: 8486-8491
21. Tamaoki T (2000) Human alpha-fetoprotein transcriptional regulatory sequences. Application to gene therapy. Adv Exp Med Biol 465: 47-56
22. Uehara K, Matsubara S, Kadomatsu K, Tsutsui J, Muramatsu T (1992) Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J Biochem 111: 563-567
23. Varagona G, Brown D, Haase A, Dusheiko G (1992) Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization. Liver 12: 62-68
24. Wesseling JG, Yamamoto M, Adachi Y, Bosma PJ, van Wijland M, Blackwell JL, Li H, Reynolds PN, Dmitriev I, Vickers SM, Huibregtse K, Curiel DT (2001) Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma. Cancer Gene Ther 8: 990-996
25. Yoshida Y, Tomizawa M, Bahar R, Miyauchi M, Yamaguchi T, Saisho H, Kadomatsu K, Muramatsu T, Matsubara S, Sakiyama S, Tagawa M (2002) A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer. Anticancer Res 22: 117-120